Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:8 Issue:11 Number:9 ISSN#:2563-5476
ACE Report #12039
Ace Report Cover General Orthopaedics

OTA 2019: Feasibility trial comparing IFF to DFR for distal femoral fractures in osteoporotic elders

How to Cite

OrthoEvidence. OTA 2019: Feasibility trial comparing IFF to DFR for distal femoral fractures in osteoporotic elders. ACE Report. 2019;8(11):9. Available from: https://myorthoevidence.com/AceReport/Report/12039

Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Knee Fix or Replace Trial (KFORT): A Randomized Controlled Feasibility Study

Contributing Authors: JM Queally ML Costa P Hull D Chou S Lewis AD Carrothers A Allison G Barton

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.


23 patients across 7 centers were recruited to a feasibility study investigating the differences between internal fracture fixation (IFF) and distal femoral replacement (DFR) and the viability of a full scale randomized trial. Outcomes of interest included the EuroQol-5 Dimensions (EQ-5D) questionnaire at 6 months post-injury (primary), in-patient costs and estimates of standard deviation to infor...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

For Reprints and Permissions, click here

Please Login or Join to leave comments.